AMA adopts policy for long-haul COVID-19 and other post-viral syndromes
The American Medical Association (AMA) has adopted a policy aimed at improving the assessment, diagnosis, and awareness of post viral syndromes.
Specifically, the new policy calls for the AMA to advocate for legislation to provide funding for research, prevention, control, and treatment of post viral syndromes and long-term sequelae associated with viral infections, such as COVID-19. Under the policy, the AMA will provide physicians and medical students with accurate and current information on post-viral syndromes and collaborate with other medical and educational entities to promote education among patients about post viral syndromes — helping minimize the harm and disability current and future patients face.
“There is much we still don’t know about COVID-19 and while many people with COVID-19 recover in the weeks following illness, we’re seeing patients experiencing symptoms that either last, or appear, many weeks or months after becoming infected,” said AMA Board Member Sandra Adamson Fryhofer, MD. “Yet, our country currently lacks the necessary resources to adequately support and provide expert care to patients with long-haul COVID. That’s why we must continue following the science and conducting research so we can better understand the short and long-term health impacts of this novel illness.”
